Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Brepocitinib doses hold promise in treatment of psoriatic arthritis
Treatment with brepocitinib at 30 and 60 mg daily outperforms placebo at relieving signs and symptoms of psoriatic arthritis (PsA), with a safety profile consistent with that seen in other brepocitinib trials, according to data from a phase IIb study.
Brepocitinib doses hold promise in treatment of psoriatic arthritis
26 May 2023
Which COVID-19 vaccine should SARDs patients on immunomodulators use?
Vaccination with either BNT162b2 or mRNA-1273 results in a comparable risk of breakthrough COVID-19 infection among patients with systemic autoimmune rheumatic diseases (SARDs) using immunomodulatory medication, a study has shown.
Which COVID-19 vaccine should SARDs patients on immunomodulators use?
26 May 2023
Fibromyalgia symptoms weakly predict RA activity after treatment
Higher levels of fibromyalgia (FM) symptoms in patients with rheumatoid arthritis (RA) are slightly indicative of worse disease activity following treatment with a disease-modifying antirheumatic drug (DMARD), suggest the results a recent study.
Fibromyalgia symptoms weakly predict RA activity after treatment
24 May 2023
Selective autotaxin inhibition shows promise in diffuse cutaneous systemic sclerosis
The selective autotaxin inhibitor ziritaxestat shows therapeutic potential in patients with early diffuse cutaneous systemic sclerosis, conferring greater reductions in modified Rodnan skin score compared with placebo and potentially reducing fibrosis, according to data from the phase IIa NOVESA study.
Selective autotaxin inhibition shows promise in diffuse cutaneous systemic sclerosis
23 May 2023
Rheumatologists need to match patient’s health literacy, says study
Communication between physicians and patients with systemic lupus erythematosus (SLE) leaves a lot to be desired, with a recent study suggesting that rheumatologists must beef up communication to match the health literacy (HL) of their patients. Doing so may foster trust and improve self-management and outcomes in SLE.
Rheumatologists need to match patient’s health literacy, says study
22 May 2023
Comorbidities fewer prior to onset of giant cell arteritis
Patients with giant cell arteritis (GCA) have a lower prevalence of diabetes mellitus as well as median fasting blood glucose (FBG) and body mass index (BMI) up to 5 years prior to diagnosis, according to a study, indicating the influence of metabolic factors on the risk of GCA.
Comorbidities fewer prior to onset of giant cell arteritis
29 Apr 2023
Musculoskeletal surgery not uncommon in psoriatic arthritis
Psoriatic arthritis (PsA) that requires musculoskeletal (MSK) surgery affects more than one in 10 patients (11.8 percent), reveals a study, adding that markers of cumulative disease activity and damage are associated with a greater need for a surgical procedure.